Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Chelsea Therapeutics International Ltd.    CHTP   US1634281059

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancials 
Company
Chelsea Therapeutics International Ltd. is a development stage biopharmaceutical company, which seeks to acquires, develops and commercializes innovative products for the treatment of a variety of human diseases, including central nervous system disorders.The company product includes... 
More about the company
Chart CHELSEA THERAPEUTICS INTER
Duration : Period :
Chelsea Therapeutics Inter Technical Analysis Chart | CHTP | US1634281059 | 4-Traders
Full-screen chart
Latest news on CHELSEA THERAPEUTICS INTER
06/29 H LUNDBECK A/S : Lundbeck Acquires Chelsea Therapeutics
06/29 CHELSEA THERAPEUTICS : Lundbeck Purchases Chelsea Therapeutics International
06/27 H LUNDBECK A/S : Lundbeck Buys Chelsea Therapeutics
06/27 CHELSEA THERAPEUTICS : Lundbeck Acquires Chelsea Therapeutics International
06/24 CHELSEA THERAPEUTICS : Notice of Delisting or Failure to Satisfy a Continued Lis..
06/23 CHELSEA THERAPEUTICS : Lundbeck successfully completes tender offer for Chelsea ..
06/19 CHELSEA THERAPEUTICS : NORTHERA(TM) Clinical Trial Data Published in Neurology
06/12 Chelsea Therapeutics Presents Efficacy and Safety Data for NORTHERA at Intern..
06/06 CHELSEA THERAPEUTICS : Announces the Expiration of the Hart-Scott-Rodino Waiting..
05/21 CHELSEA THERAPEUTICS : Acquisition Chelsea Therapeutics International, Ltd by H...
05/21 CHELSEA THERAPEUTICS : Shareholder Alert: Former SEC Attorney Willie Briscoe and..
05/15 CHELSEA THERAPEUTICS : INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investiga..
More news


Comments 
Advertisement
Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF